RU2016133471A3 - - Google Patents

Download PDF

Info

Publication number
RU2016133471A3
RU2016133471A3 RU2016133471A RU2016133471A RU2016133471A3 RU 2016133471 A3 RU2016133471 A3 RU 2016133471A3 RU 2016133471 A RU2016133471 A RU 2016133471A RU 2016133471 A RU2016133471 A RU 2016133471A RU 2016133471 A3 RU2016133471 A3 RU 2016133471A3
Authority
RU
Russia
Application number
RU2016133471A
Other languages
Russian (ru)
Other versions
RU2016133471A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016133471A publication Critical patent/RU2016133471A/ru
Publication of RU2016133471A3 publication Critical patent/RU2016133471A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2016133471A 2014-02-14 2015-02-11 Композиции и способы для лечения диабета и заболеваний печени RU2016133471A (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461939961P 2014-02-14 2014-02-14
US61/939,961 2014-02-14
US201461984225P 2014-04-25 2014-04-25
US61/984,225 2014-04-25
US201462086911P 2014-12-03 2014-12-03
US62/086,911 2014-12-03
PCT/US2015/015353 WO2015123256A1 (en) 2014-02-14 2015-02-11 Compositions and methods for treating diabetes and liver diseases

Publications (2)

Publication Number Publication Date
RU2016133471A RU2016133471A (ru) 2018-03-19
RU2016133471A3 true RU2016133471A3 (cg-RX-API-DMAC7.html) 2018-09-24

Family

ID=53800574

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016133471A RU2016133471A (ru) 2014-02-14 2015-02-11 Композиции и способы для лечения диабета и заболеваний печени

Country Status (12)

Country Link
US (1) US20170165286A1 (cg-RX-API-DMAC7.html)
EP (1) EP3105234A4 (cg-RX-API-DMAC7.html)
JP (2) JP6553067B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160113307A (cg-RX-API-DMAC7.html)
CN (1) CN106132969A (cg-RX-API-DMAC7.html)
AU (1) AU2015217293A1 (cg-RX-API-DMAC7.html)
CA (1) CA2939076A1 (cg-RX-API-DMAC7.html)
IL (1) IL247152A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016010447A (cg-RX-API-DMAC7.html)
RU (1) RU2016133471A (cg-RX-API-DMAC7.html)
WO (1) WO2015123256A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201606199B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
HRP20160222T1 (hr) 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CA2884481C (en) 2012-09-17 2021-04-27 Madrigal Pharmaceuticals, Inc. Method of synthesizing thyroid hormone analogs and polymorphs thereof
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
DK3528817T3 (da) 2016-10-18 2022-08-08 Madrigal Pharmaceuticals Inc Fremgangsmåder til behandling af leverforstyrrelser eller lipidforstyrrelser med en thr-beta-agonist
CN110198719A (zh) * 2016-11-21 2019-09-03 维京治疗公司 治疗糖原贮积病的方法
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760010A (en) * 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
FR2897154B1 (fr) * 2006-02-08 2008-03-07 Airbus France Sas Dispositif pour construire et securiser une trajectoire de vol a basse altitude destinee a etre suivie par un aeronef.
CN103193840A (zh) * 2006-05-01 2013-07-10 大正制药株式会社 大环内酯衍生物
JP5025249B2 (ja) * 2006-12-15 2012-09-12 Nskワーナー株式会社 発進クラッチ
JP5150740B2 (ja) * 2011-01-21 2013-02-27 株式会社小松製作所 作業車両
PT2872510T (pt) * 2011-08-30 2017-03-01 Wockhardt Ltd Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infeções bacterianas
US9078975B2 (en) * 2011-09-30 2015-07-14 Becton Dickinson France, S.A.S. Syringe having pivoting arm plunger rod

Also Published As

Publication number Publication date
EP3105234A1 (en) 2016-12-21
US20170165286A1 (en) 2017-06-15
WO2015123256A1 (en) 2015-08-20
MX2016010447A (es) 2016-12-20
CN106132969A (zh) 2016-11-16
AU2015217293A1 (en) 2016-09-01
JP2017505785A (ja) 2017-02-23
JP6553067B2 (ja) 2019-07-31
ZA201606199B (en) 2020-01-29
JP2019189639A (ja) 2019-10-31
IL247152A0 (en) 2016-09-29
KR20160113307A (ko) 2016-09-28
EP3105234A4 (en) 2017-11-08
CA2939076A1 (en) 2015-08-20
RU2016133471A (ru) 2018-03-19

Similar Documents

Publication Publication Date Title
BR112016017659A2 (cg-RX-API-DMAC7.html)
BR112016018076A2 (cg-RX-API-DMAC7.html)
BR112016018374A2 (cg-RX-API-DMAC7.html)
BR112016019234A2 (cg-RX-API-DMAC7.html)
BR112016019490A2 (cg-RX-API-DMAC7.html)
BR112016016432A2 (cg-RX-API-DMAC7.html)
BR112016015813A2 (cg-RX-API-DMAC7.html)
BR112016016705A2 (cg-RX-API-DMAC7.html)
BR112016017278A2 (cg-RX-API-DMAC7.html)
BR112016016602A2 (cg-RX-API-DMAC7.html)
BR112016015971A2 (cg-RX-API-DMAC7.html)
BR112016017767A2 (cg-RX-API-DMAC7.html)
BR112016017265A2 (cg-RX-API-DMAC7.html)
BR112016015311A2 (cg-RX-API-DMAC7.html)
BR112016018384A2 (cg-RX-API-DMAC7.html)
BR112016019276A2 (cg-RX-API-DMAC7.html)
BR112016016770A2 (cg-RX-API-DMAC7.html)
BR112016016451A2 (cg-RX-API-DMAC7.html)
BR112016015385A2 (cg-RX-API-DMAC7.html)
BR112016018865A2 (cg-RX-API-DMAC7.html)
BR112016003131A2 (cg-RX-API-DMAC7.html)
BR112016019012A2 (cg-RX-API-DMAC7.html)
BR112016017226A2 (cg-RX-API-DMAC7.html)
BR112016019248A2 (cg-RX-API-DMAC7.html)
BR112016016823A2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20190513